Seed VC · Singapore, Singapore
4BIO Capital is a London-based investment firm founded in 2018, specializing in advanced therapies and biotechnology. The company focuses on funding and supporting early-stage and growth-stage companies developing innovative treatments in areas such as gene therapy, cell therapy, RNA-based drugs, and targeted therapies. 4BIO Capital manages several funds and collaborates with academic institutions, research organizations, and industry partners to accelerate the development of transformative medical solutions. The firm is recognized for its expertise in the life sciences sector and its commitment to advancing next-generation therapeutics.
Business models
biotech_therapeutics, deeptech_ip
Customer segments
Researchers, Healthcare providers
Geography
UK, Europe, USA, APAC
We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.
4BIO Capital writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks 4BIO Capital alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Family Office
Lobnek Wealth Management
life sciences, private equity, M&A
Family Office
Aeternum Management AS
life sciences, healthcare, medical devices
Family Office
SK Capital Partners
specialty materials, ingredients, life sciences
Seed VC
North Point Securities
corporate finance, equity research, life sciences
Family Office
EQT Foundation
deeptech, life sciences, climate tech
Family Office
Hitma Groep B.V.
technical components and systems distribution, process filtration, life sciences
Drop your pitch. AI scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. 4BIO Capital is one of them — and we'll tell you exactly where they sit in your top 100.